Tango Historical Financial Ratios

TNGX Stock  USD 3.10  0.16  5.44%   
Tango Therapeutics is promptly reporting on over 91 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 2.1, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 0.55 will help investors to properly organize and evaluate Tango Therapeutics financial condition quickly.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tango Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Tango Stock please use our How to Invest in Tango Therapeutics guide.

About Tango Financial Ratios Analysis

Tango TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Tango Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Tango financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Tango Therapeutics history.

Tango Therapeutics Financial Ratios Chart

At this time, Tango Therapeutics' PTB Ratio is fairly stable compared to the past year. Days Sales Outstanding is likely to rise to 52.95 in 2024, whereas Price To Sales Ratio is likely to drop 19.37 in 2024.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.
Most ratios from Tango Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Tango Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tango Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Tango Stock please use our How to Invest in Tango Therapeutics guide.At this time, Tango Therapeutics' PTB Ratio is fairly stable compared to the past year. Days Sales Outstanding is likely to rise to 52.95 in 2024, whereas Price To Sales Ratio is likely to drop 19.37 in 2024.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding19.7129.3633.7752.95
PTB Ratio1.972.553.76.45

Tango Therapeutics fundamentals Correlations

-0.62-0.490.440.960.97-0.39-0.621.00.980.660.460.41-0.47-0.790.410.360.220.880.210.67-0.940.630.19-0.360.17
-0.620.99-0.91-0.51-0.510.211.0-0.6-0.53-0.98-0.72-0.930.740.72-0.33-0.390.6-0.540.6-0.690.36-0.980.610.69-0.57
-0.490.99-0.91-0.38-0.380.210.99-0.48-0.4-0.96-0.71-0.970.730.62-0.26-0.360.71-0.450.71-0.610.22-0.970.730.72-0.58
0.44-0.91-0.910.430.4-0.21-0.910.40.430.880.40.91-0.41-0.70.110.65-0.680.45-0.680.76-0.260.88-0.64-0.830.85
0.96-0.51-0.380.430.99-0.49-0.510.951.00.580.20.35-0.22-0.760.220.540.270.920.260.68-0.970.550.26-0.450.26
0.97-0.51-0.380.40.99-0.41-0.510.961.00.560.250.32-0.26-0.80.320.50.310.890.310.7-0.980.530.3-0.370.22
-0.390.210.21-0.21-0.49-0.410.21-0.38-0.42-0.360.07-0.390.01-0.060.64-0.30.14-0.770.160.070.34-0.370.160.680.0
-0.621.00.99-0.91-0.51-0.510.21-0.6-0.53-0.98-0.72-0.930.740.72-0.33-0.390.6-0.540.6-0.690.36-0.980.610.69-0.57
1.0-0.6-0.480.40.950.96-0.38-0.60.970.650.490.39-0.5-0.770.430.310.240.870.230.63-0.930.620.2-0.320.11
0.98-0.53-0.40.431.01.0-0.42-0.530.970.590.270.35-0.28-0.80.320.50.280.90.270.7-0.980.560.27-0.40.24
0.66-0.98-0.960.880.580.56-0.36-0.980.650.590.660.95-0.7-0.680.240.45-0.580.65-0.590.64-0.411.0-0.61-0.760.5
0.46-0.72-0.710.40.20.250.07-0.720.490.270.660.57-0.99-0.380.59-0.33-0.330.22-0.330.24-0.160.67-0.41-0.1-0.04
0.41-0.93-0.970.910.350.32-0.39-0.930.390.350.950.57-0.61-0.490.010.44-0.80.5-0.80.5-0.140.96-0.81-0.850.59
-0.470.740.73-0.41-0.22-0.260.010.74-0.5-0.28-0.7-0.99-0.610.36-0.540.30.36-0.270.37-0.210.16-0.70.450.160.07
-0.790.720.62-0.7-0.76-0.8-0.060.72-0.77-0.8-0.68-0.38-0.490.36-0.61-0.60.0-0.55-0.01-0.970.75-0.65-0.030.37-0.6
0.41-0.33-0.260.110.220.320.64-0.330.430.320.240.590.01-0.54-0.61-0.150.23-0.060.240.49-0.350.220.190.4-0.03
0.36-0.39-0.360.650.540.5-0.3-0.390.310.50.45-0.330.440.3-0.6-0.15-0.210.49-0.210.72-0.440.44-0.13-0.70.77
0.220.60.71-0.680.270.310.140.60.240.28-0.58-0.33-0.80.360.00.23-0.210.061.0-0.09-0.47-0.610.990.65-0.5
0.88-0.54-0.450.450.920.89-0.77-0.540.870.90.650.220.5-0.27-0.55-0.060.490.060.050.47-0.820.630.04-0.630.18
0.210.60.71-0.680.260.310.160.60.230.27-0.59-0.33-0.80.37-0.010.24-0.211.00.05-0.08-0.47-0.610.990.66-0.5
0.67-0.69-0.610.760.680.70.07-0.690.630.70.640.240.5-0.21-0.970.490.72-0.090.47-0.08-0.650.62-0.04-0.450.76
-0.940.360.22-0.26-0.97-0.980.340.36-0.93-0.98-0.41-0.16-0.140.160.75-0.35-0.44-0.47-0.82-0.47-0.65-0.38-0.460.22-0.14
0.63-0.98-0.970.880.550.53-0.37-0.980.620.561.00.670.96-0.7-0.650.220.44-0.610.63-0.610.62-0.38-0.63-0.770.5
0.190.610.73-0.640.260.30.160.610.20.27-0.61-0.41-0.810.45-0.030.19-0.130.990.040.99-0.04-0.46-0.630.63-0.4
-0.360.690.72-0.83-0.45-0.370.680.69-0.32-0.4-0.76-0.1-0.850.160.370.4-0.70.65-0.630.66-0.450.22-0.770.63-0.67
0.17-0.57-0.580.850.260.220.0-0.570.110.240.5-0.040.590.07-0.6-0.030.77-0.50.18-0.50.76-0.140.5-0.4-0.67
Click cells to compare fundamentals

Tango Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tango Stock Analysis

When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.